To discuss the market for medicinal cannabis in Australia, Dr Andrew Beehag, CEO of Canndeo, a subsidiary of ASX-listed The Hydroponics Company, joins the show.
X
"I share market commentary on TV, radio, and on
Start Trial
Free for 21 days Subscribe Now
and find out more
"I share market commentary on TV, radio, and on
Switzer Daily, but for Subscribers I tell them
EXACTLY how I’m investing my money, and I hold nothing back!"
Start TrialFree for 21 days Subscribe Now
and find out more
